Zymeworks
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zymeworks and other ETFs, options, and stocks.About ZYME
Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2).
CEOKenneth Harry Galbraith
CEOKenneth Harry Galbraith
Employees264
Employees264
HeadquartersMiddletown, Delaware
HeadquartersMiddletown, Delaware
Founded2003
Founded2003
Employees264
Employees264
ZYME Key Statistics
Market cap2.06B
Market cap2.06B
Price-Earnings ratio-25.70
Price-Earnings ratio-25.70
Dividend yield—
Dividend yield—
Average volume669.94K
Average volume669.94K
High today$27.96
High today$27.96
Low today$26.91
Low today$26.91
Open price$27.16
Open price$27.16
Volume790.37K
Volume790.37K
52 Week high$28.49
52 Week high$28.49
52 Week low$10.69
52 Week low$10.69
Stock Snapshot
The current Zymeworks(ZYME) stock price is $27.96, with a market capitalization of 2.06B. The stock trades at a price-to-earnings (P/E) ratio of -25.70.
As of 2026-04-15, Zymeworks(ZYME) stock has fluctuated between $26.91 and $27.96. The current price stands at $27.96, placing the stock +3.9% above today's low and 0.0% off the high.
The Zymeworks(ZYME)'s current trading volume is 790.37K, compared to an average daily volume of 669.94K.
During the past year, Zymeworks(ZYME) stock moved between $10.69 at its lowest and $28.49 at its peak.
During the past year, Zymeworks(ZYME) stock moved between $10.69 at its lowest and $28.49 at its peak.
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ZYME. This list is generated using Robinhood data, and it’s not a recommendation.